Difference between revisions of "WSI24-289-Case-6"

From MGH Learn Pathology
(Creating page)
 
 
Line 1: Line 1:
 
{{ServiceRequestCase
 
{{ServiceRequestCase
|identifier=WSI24-289-Case-6
+
|requisition=Lower GI slide session- GI Pathology CME
 +
|subject=MGH
 
|intent=order
 
|intent=order
 +
|category=409073007
 +
|occurrenceDateTime=2025-05-12T20:00:00+00:00
 +
|basedOn=WSI24-289
 +
|priority=Routine
 
|code=cme
 
|code=cme
|category=409073007
+
|orderDetail=case
|subject=MGH
+
|authoredOn=2025-04-17T19:22:16.477779+00:00
 
|requester=Jg67
 
|requester=Jg67
 +
|locationCode=learn
 +
|sequence=6
 
|performer=Jg67
 
|performer=Jg67
|orderDetail=case
 
|locationCode=learn
 
|access=public
 
|status=active
 
|origin=CPOE
 
|priority=Routine
 
|basedOn=WSI24-289
 
|requisition=Lower GI slide session- GI Pathology CME
 
 
|reasonCode=51 y.o. female with neurofibromatosis​
 
|reasonCode=51 y.o. female with neurofibromatosis​
 
Positive Cologuard, otherwise asymptomatic​; Ileocolonic mass (tumor vs. Inflammatory), biopsies nondiagnostic
 
Positive Cologuard, otherwise asymptomatic​; Ileocolonic mass (tumor vs. Inflammatory), biopsies nondiagnostic
|occurrenceDateTime=2025-05-12T20:00:00+00:00
 
|authoredOn=2025-04-17T19:22:16.477779+00:00
 
|specimen=
 
|sequence=6
 
 
|supportingInfo=Ileal inflammatory fibroid polyps​. Submucosal lipoma at ileocecal valve​. Secondary mucosal changes in ileal mucosa​
 
|supportingInfo=Ileal inflammatory fibroid polyps​. Submucosal lipoma at ileocecal valve​. Secondary mucosal changes in ileal mucosa​
No neurofibromatous lesions.  
+
No neurofibromatous lesions.
|bodySite=
+
|identifier=WSI24-289-Case-6
|replaces=
+
|access=public
}}
 
{{status
 
 
|status=active
 
|status=active
|requester=Jg67
+
|origin=CPOE
|authoredOn=2025-04-17T19:22:16.477779+00:00
 
 
}}
 
}}
 
{{Media
 
{{Media
|identifier=9a26d39d-684d-47f8-9af9-788275eddd67
+
|createdDateTime=2025-04-17T19:22:16.477779+00:00
|basedOn=WSI24-289-Case-6
+
|operator=Jg67
 +
|frames=1
 
|status=completed
 
|status=completed
|frames=1
 
|operator=Jg67
 
 
|reasonCode=H&E
 
|reasonCode=H&E
|content=dbbcb112-1dbc-4fc9-9fe2-d2576919bb36.mrxs
 
 
|view=show
 
|view=show
|createdDateTime=2025-04-17T19:22:16.477779+00:00
+
|identifier=9a26d39d-684d-47f8-9af9-788275eddd67
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=885ba397-cec1-48dc-aa62-8a324c728e9c
+
|createdDateTime=2025-04-17T19:22:16.477779+00:00
|basedOn=WSI24-289-Case-6
+
|operator=Jg67
 +
|frames=2
 
|status=completed
 
|status=completed
|frames=2
 
|operator=Jg67
 
 
|reasonCode=H&E
 
|reasonCode=H&E
|content=dca89f6e-c326-433f-82a9-c430e064398b.mrxs
 
 
|view=show
 
|view=show
|createdDateTime=2025-04-17T19:22:16.477779+00:00
+
|identifier=885ba397-cec1-48dc-aa62-8a324c728e9c
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=9ae110be-34bb-4af7-afdb-b4e808715d3f
+
|createdDateTime=2025-04-17T19:22:16.477779+00:00
|basedOn=WSI24-289-Case-6
+
|operator=Jg67
 +
|frames=3
 
|status=completed
 
|status=completed
|frames=3
 
|operator=Jg67
 
 
|reasonCode=H&E
 
|reasonCode=H&E
|content=d2d37df3-af2a-4f12-a6ba-70ab159e11c3.mrxs
 
 
|view=show
 
|view=show
|createdDateTime=2025-04-17T19:22:16.477779+00:00
+
|identifier=9ae110be-34bb-4af7-afdb-b4e808715d3f
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=49295027-6931-4e11-9db8-d76ffd6a5f06
+
|createdDateTime=2025-04-17T19:22:16.477779+00:00
|basedOn=WSI24-289-Case-6
+
|operator=Jg67
 +
|frames=4
 
|status=completed
 
|status=completed
|frames=4
 
|operator=Jg67
 
 
|reasonCode=H&E
 
|reasonCode=H&E
|content=c9f469f5-14ea-4371-81ec-9f8e7e004a54.mrxs
 
 
|view=show
 
|view=show
|createdDateTime=2025-04-17T19:22:16.477779+00:00
+
|identifier=49295027-6931-4e11-9db8-d76ffd6a5f06
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=54cd6556-ebc2-4233-8abd-b5a449ac13c5
+
|createdDateTime=2025-04-17T19:22:16.477779+00:00
|basedOn=WSI24-289-Case-6
+
|operator=Jg67
 +
|frames=5
 
|status=completed
 
|status=completed
|frames=5
 
|operator=Jg67
 
 
|reasonCode=H&E
 
|reasonCode=H&E
|content=dd69521e-ebf5-48c9-b0c2-135dd21de0c2.mrxs
 
 
|view=show
 
|view=show
|createdDateTime=2025-04-17T19:22:16.477779+00:00
+
|identifier=54cd6556-ebc2-4233-8abd-b5a449ac13c5
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=620a9824-5537-4483-b703-5c603abc0b62
+
|createdDateTime=2025-04-17T19:22:16.477779+00:00
|basedOn=WSI24-289-Case-6
+
|operator=Jg67
 +
|frames=6
 
|status=completed
 
|status=completed
|frames=6
 
|operator=Jg67
 
 
|reasonCode=H&E
 
|reasonCode=H&E
|content=27f39a30-2cf6-442a-8388-a12e94aca7db.mrxs
 
 
|view=show
 
|view=show
|createdDateTime=2025-04-17T19:22:16.477779+00:00
+
|identifier=620a9824-5537-4483-b703-5c603abc0b62
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=06d07708-cb1b-4ee5-98e3-49142aa5160d
+
|createdDateTime=2025-04-17T19:22:16.477779+00:00
|basedOn=WSI24-289-Case-6
+
|operator=Jg67
 +
|frames=7
 
|status=completed
 
|status=completed
|frames=7
 
|operator=Jg67
 
 
|reasonCode=H&E
 
|reasonCode=H&E
|content=28c4a68b-2d8d-4d93-b4be-9f832c4c299d.mrxs
 
 
|view=show
 
|view=show
|createdDateTime=2025-04-17T19:22:16.477779+00:00
+
|identifier=06d07708-cb1b-4ee5-98e3-49142aa5160d
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=9176bfe9-f490-40f7-977f-21c559787b33
+
|createdDateTime=2025-04-17T19:22:16.477779+00:00
|basedOn=WSI24-289-Case-6
+
|operator=Jg67
 +
|frames=8
 
|status=completed
 
|status=completed
|frames=8
 
|operator=Jg67
 
|reasonCode=HE Surf. Recut 5u
 
|content=2a314e18-374a-4e00-b561-2f1709b221c1.mrxs
 
 
|view=show
 
|view=show
|createdDateTime=2025-04-17T19:22:16.477779+00:00
+
|identifier=9176bfe9-f490-40f7-977f-21c559787b33
 
}}
 
}}
 
 
{{Media
 
{{Media
 +
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 +
|operator=Jg67
 +
|frames=9
 +
|status=completed
 +
|view=hide
 
|identifier=00380e85-6e9c-46fd-9d5a-d8a33a94c0cd
 
|identifier=00380e85-6e9c-46fd-9d5a-d8a33a94c0cd
|basedOn=WSI24-289-Case-6
 
|status=completed
 
|frames=9
 
|operator=Jg67
 
|reasonCode=CD34 Heme (TC) B3
 
|content=d3d24bb3-99b7-4c09-bf21-91f8b04bb36e.mrxs
 
|view=show
 
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 
 
}}
 
}}
 
 
{{Media
 
{{Media
 +
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 +
|operator=Jg67
 +
|frames=10
 +
|status=completed
 +
|view=hide
 
|identifier=6a105ec2-a1c0-45e0-a868-5fcc201ef4e5
 
|identifier=6a105ec2-a1c0-45e0-a868-5fcc201ef4e5
|basedOn=WSI24-289-Case-6
 
|status=completed
 
|frames=10
 
|operator=Jg67
 
|reasonCode=PDGFRA (GIST) B7
 
|content=027459d8-1a54-4308-9ccf-614454bbb474.mrxs
 
|view=show
 
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 
 
}}
 
}}
 
 
{{Media
 
{{Media
 +
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 +
|operator=Jg67
 +
|frames=11
 +
|status=completed
 +
|view=hide
 
|identifier=e4b7b7f3-c477-4c5b-8b0d-be931357493c
 
|identifier=e4b7b7f3-c477-4c5b-8b0d-be931357493c
|basedOn=WSI24-289-Case-6
 
|status=completed
 
|frames=11
 
|operator=Jg67
 
|reasonCode=CD117 (T-C) B3
 
|content=d56998d7-03d1-45d4-8d20-7b430ffe59de.mrxs
 
|view=show
 
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 
 
}}
 
}}
 
 
{{Media
 
{{Media
 +
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 +
|operator=Jg67
 +
|frames=12
 +
|status=completed
 +
|view=hide
 
|identifier=1f02ece9-f2bc-44fb-b368-f4c2116dcb43
 
|identifier=1f02ece9-f2bc-44fb-b368-f4c2116dcb43
|basedOn=WSI24-289-Case-6
 
|status=completed
 
|frames=12
 
|operator=Jg67
 
|reasonCode=SMA (T-C) B5
 
|content=855b4067-db7f-4454-a8bd-f6e9f92c999a.mrxs
 
|view=show
 
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 
 
}}
 
}}
 
 
{{Media
 
{{Media
 +
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 +
|operator=Jg67
 +
|frames=13
 +
|status=completed
 +
|view=hide
 
|identifier=5da6eb34-731a-40c0-a6fb-09a613d82e75
 
|identifier=5da6eb34-731a-40c0-a6fb-09a613d82e75
|basedOn=WSI24-289-Case-6
 
|status=completed
 
|frames=13
 
|operator=Jg67
 
|reasonCode=S100 (T-C) B9
 
|content=8b79a0f5-1b25-4eaf-a020-d2ecae1c075c.mrxs
 
|view=show
 
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=892e6f33-f7f8-4376-9a49-db7846eef7c2
+
|createdDateTime=2025-04-17T19:22:16.477779+00:00
|basedOn=WSI24-289-Case-6
+
|operator=Jg67
 +
|frames=14
 
|status=completed
 
|status=completed
|frames=14
 
|operator=Jg67
 
|reasonCode=HE Surf. Recut 5u
 
|content=dfda2433-f9eb-4972-94ad-18fd509c50ce.mrxs
 
 
|view=show
 
|view=show
|createdDateTime=2025-04-17T19:22:16.477779+00:00
+
|identifier=892e6f33-f7f8-4376-9a49-db7846eef7c2
 
}}
 
}}
 
 
{{Media
 
{{Media
 +
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 +
|operator=Jg67
 +
|frames=15
 +
|status=completed
 +
|view=hide
 
|identifier=9ae2c301-c1ba-4411-a802-f12e6864508c
 
|identifier=9ae2c301-c1ba-4411-a802-f12e6864508c
|basedOn=WSI24-289-Case-6
 
|status=completed
 
|frames=15
 
|operator=Jg67
 
|reasonCode=CD34 (T-C) B3
 
|content=87767b46-140a-476a-b009-61aa6faf06cb.mrxs
 
|view=show
 
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 
 
}}
 
}}
 
 
{{Media
 
{{Media
 +
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 +
|operator=Jg67
 +
|frames=16
 +
|status=completed
 +
|view=hide
 
|identifier=e3bbb10c-2374-4b12-841d-cb5a80b75aaa
 
|identifier=e3bbb10c-2374-4b12-841d-cb5a80b75aaa
|basedOn=WSI24-289-Case-6
 
|status=completed
 
|frames=16
 
|operator=Jg67
 
|reasonCode=PDGFRA (GIST) B7
 
|content=4c507fe6-5152-48f1-b824-39c71e19a1da.mrxs
 
|view=show
 
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 
 
}}
 
}}
 
 
{{Media
 
{{Media
 +
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 +
|operator=Jg67
 +
|frames=17
 +
|status=completed
 +
|view=hide
 
|identifier=e598d935-919a-4603-b42c-f3b795289795
 
|identifier=e598d935-919a-4603-b42c-f3b795289795
|basedOn=WSI24-289-Case-6
 
|status=completed
 
|frames=17
 
|operator=Jg67
 
|reasonCode=CD117 (T-C) B3
 
|content=ab20f1c8-4c76-44d9-a968-eb91b5222f2c.mrxs
 
|view=show
 
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 
 
}}
 
}}
 
 
{{Media
 
{{Media
 +
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 +
|operator=Jg67
 +
|frames=18
 +
|status=completed
 +
|view=hide
 
|identifier=43c2c53c-257c-4cc2-bc53-a71b09fbc821
 
|identifier=43c2c53c-257c-4cc2-bc53-a71b09fbc821
|basedOn=WSI24-289-Case-6
 
|status=completed
 
|frames=18
 
|operator=Jg67
 
|reasonCode=S100 (T-C) B9
 
|content=4e23df60-b655-40ca-889c-4b61920c40a5.mrxs
 
|view=show
 
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 
 
}}
 
}}
 
 
{{Media
 
{{Media
 +
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 +
|operator=Jg67
 +
|frames=19
 +
|status=completed
 +
|view=hide
 
|identifier=c7e09ffa-f67c-46b7-aef8-8d1883b1e3d5
 
|identifier=c7e09ffa-f67c-46b7-aef8-8d1883b1e3d5
|basedOn=WSI24-289-Case-6
+
}}
|status=completed
+
{{status
|frames=19
+
|status=active
|operator=Jg67
+
|requester=Jg67
|reasonCode=SMA (T-C) B5
+
|authoredOn=2025-04-17T19:22:16.477779+00:00
|content=dae7af45-9f67-4123-b70a-325d48931db1.mrxs
 
|view=show
 
|createdDateTime=2025-04-17T19:22:16.477779+00:00
 
 
}}
 
}}

Latest revision as of 07:18, May 9, 2025

WSI24-289-Case-6
51 y.o. female with neurofibromatosis​ Positive Cologuard, otherwise asymptomatic​; Ileocolonic mass (tumor vs. Inflammatory), biopsies nondiagnostic
Ileal inflammatory fibroid polyps​. Submucosal lipoma at ileocecal valve​. Secondary mucosal changes in ileal mucosa​ No neurofibromatous lesions.
May 12, 2025 4:00:00 PM